| CYHS2403534 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2024-10-18 | | | | | view |
| JYHB1900252 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2019-02-27 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-07-16 | view |
| JYHB2101277 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2021-07-24 | | | | | view |
| JYHZ2300221 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | License Renew | 2023-05-11 | | | | | view |
| JXHL1600007 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Import Drug Application | 2016-01-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-01-15 | view |
| JYHB2002693 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2020-12-28 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | In Review | 2020-12-25 | view |
| JYHB2300133 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2023-02-21 | | | | | view |
| CYHS2403334 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2024-10-09 | | Double-Crane Pharmaceutical(Hainan) Co Ltd | | | view |
| JYHB1900174 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2019-02-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-03-21 | view |
| JYHB2101278 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2021-07-24 | | | | | view |
| JYHZ2300222 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | License Renew | 2023-05-11 | | | | | view |
| JYHB2002063 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2020-10-16 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-11-05 | view |
| CYHL2300023 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2023-02-18 | | Hybio Pharmaceutical Co Ltd | | | view |
| JYHB2002726 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2021-01-01 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-15 | view |
| CYHS2300919 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2023-03-28 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JYHF2000048 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2020-05-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-26 | view |
| CYHS2201778 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2022-10-19 | | Double-Crane Pharmaceutical(Hainan) Co Ltd | | | view |
| CYHS2402190 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2024-07-16 | | Sichuan Gowell Pharmaceutical Co Ltd | | | view |
| JYHB1900125 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs | Supplementary Application | 2019-01-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2019-02-13 | view |
| CYHS2300918 | 利那洛肽胶囊 | linaclotide | Capsule | Chemical Drugs(4) | Generic Drug | 2023-03-28 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
